State Ledger
Company profile

Nuvectis Pharma, Inc. CIK 1875558

Ticker
NVCT (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Fort Lee, NJ 07024
Fiscal year end
2025 (FY)
Market Data
Close
$21.11
Change
+$0.98
Change %
4.87%
Volume
6,165

NVCT · trading date Oct 9, 2026 · previous close $20.13 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$26.44M
Total assets
$31.71M
Total liabilities
$13.30M
Stockholders' equity
$18.41M
Cash & equivalents
$31.63M
Operating income
-$27.57M
Operating cash flow
-$16.01M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-02-11. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
41.9%
Equity / assets
58.1%
CapEx / revenue
—
Operating cash flow / net income
0.61×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$26.44M $31.71M $13.30M $18.41M
2024 — -$19.00M $18.61M $8.89M $9.71M
2023 — -$22.26M $19.19M $6.98M $12.20M
2022 — -$19.09M $20.41M $6.19M $14.22M
2021 — -$12.89M $6.66M $2.42M -$11.01M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form EFFECT
2026-08-28
Financials filed via
Form 10-K
filed 2026-02-11

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Fort Lee, NJ 07024
1 BRIDGE PLAZA, SUITE 275
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:40 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New Jersey — Public Companies